Results 91 to 100 of about 27,191 (241)

Intrathoracic Extramedullary Hematopoiesis Arising in the Anterior Mediastinum

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
Arrows indicate enlarging anterior (a, b) and posterior (c, d) mediastinal extramedullary hematopoiesis (EMH). EMH should be included in the differential diagnosis of anterior mediastinal lesion. Histologic confirmation is desirable to obtain definitive diagnosis and guide management.
Yoshiki Kozu   +3 more
wiley   +1 more source

Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes

open access: yes, 2014
Tariq I Mughal,1 Kris Vaddi,2 Nicholas J Sarlis,2 Srdan Verstovsek31Tufts University School of Medicine, Boston, MA, 2Incyte Corporation, Wilmington, DE, 3Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USAAbstract ...
Mughal TI   +3 more
core  

Osteogenic Potential of Mesenchymal Stromal Cells Contributes to Primary Myelofibrosis. [PDF]

open access: yes, 2015
International audiencePrimary myelofibrosis is a myeloproliferative neoplasm that is a precursor to myeloid leukemia. Dysmegakaryopoiesis and extramedullary hematopoiesis characterize primary myelofibrosis, which is also associated with bone marrow ...
Torossian, Frédéric   +20 more
core   +1 more source

Beta Thalassemia and Chronic Myeloid Leukemia: Dual Diagnosis Under the Microscope

open access: yes
International Journal of Laboratory Hematology, EarlyView.
Paige Muir   +3 more
wiley   +1 more source

Cytokine receptor and JAK/STAT pathway mutations in acute myeloid leukemia: Prevalence and clinical impact

open access: yesCancer, Volume 132, Issue 11, 1 June 2026.
Abstract Background Mutations in cytokine receptor and JAK/STAT; Cy‐JAK/STAT) signaling genes drive myeloproliferative neoplasms (MPNs) but remain incompletely characterized in acute myeloid leukemia (AML). The authors evaluated the prevalence, clinical presentation, and prognostic significance of Cy‐JAK/STAT pathway mutations in patients with AML and ...
Moath Albliwi   +22 more
wiley   +1 more source

Primary myelofibrosis: when the clone manifests with Rh phenotype splitting

open access: yes, 2014
Rh phenotype splitting in primary ...
Orlando, Nicoletta   +7 more
core   +1 more source

Myelofibrosis with myeloid metaplasia (MMM) [PDF]

open access: yes, 1998
Review on Myelofibrosis with myeloid metaplasia (MMM), with data on clinics, and the genes ...
Huret, JL
core   +1 more source

On Myelofibrosis

open access: yes, 2022
Part I. Imaging in myelofibrosis Bone marrow (BM) biopsies have several limitations, which complicate the reliable evaluation of disease activity in myelofibrosis. We evaluated the potential value of imaging techniques as an alternative method. Chapter 2 describes the results of our systematic literature review.
openaire   +2 more sources

Pacritinib Impact on QT Interval: Results of a Thorough QT Study and Post Hoc Analysis of Prospective Clinical Trial Data

open access: yesClinical Pharmacology in Drug Development, Volume 15, Issue 6, June 2026.
Abstract Pacritinib, an inhibitor of JAK2/IRAK1/ACVR1 that is devoid of JAK1 activity, approved for treating myelofibrosis in patients with severe thrombocytopenia, carries a label warning for QT interval prolongation. To evaluate the cardiac safety of pacritinib, a randomized, placebo‐ and active‐controlled, single‐dose thorough QT (TQT) study was ...
Sarah A. Buckley   +5 more
wiley   +1 more source

Increased angiogenesis in primary myelofibrosis: latent transforming growth factor-β as a possible angiogenic factor

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2014
Objective: The aim of this work was to demonstrate a possible relationship between anti-latency-associated peptide human latent transforming growth factor beta 1 (latent TGF-β1) expression in megakaryocytes and microvascular density in bone marrow ...
Cesar Cilento Ponce   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy